Abeona Therapeutics Inc. (ABEO) Ownership

NASDAQ: ABEOTop holders, insider trades and short interest.

ABEO ownership summary

as of October 17, 2026
Institutions
75.1%
of shares outstanding
Insiders
10.96%
of shares outstanding
Shares outstanding
57.2M
Float
36.9M
shares available to trade
Short interest
31.69%
16.9M shares short
Days to cover
12.15
short interest up 7.2% vs prior month
  • Institutions 75.07%
  • Insiders 10.96%
  • Other investors 13.97%

ABEO top institutional holders

20 largest
Abeona Therapeutics Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Nantahala Capital Management, LLC17.96%10.3M$45.5M+5.3M (+104.9%)June 30, 2026
2BlackRock Inc5.86%3.4M$14.9M+156,944 (+4.9%)June 30, 2026
3Cable Car Capital LLC5.26%3.0M$13.3M—June 30, 2026
4AIGH Capital Management, LLC5.22%3.0M$13.2M−113,000 (−3.6%)June 30, 2026
5Vanguard Capital Management, LLC3.87%2.2M$9.8M+46,582 (+2.2%)June 30, 2026
6Resources Investment Advisors Inc2.89%1.7M$7.3M+1.7M (0.0%)June 30, 2026
7Awm Investment Company Inc2.60%1.5M$6.6M+683,000 (+85.0%)June 30, 2026
8Geode Capital Management, LLC2.21%1.3M$5.6M+51,293 (+4.2%)June 30, 2026
9Kennedy Capital Management Inc2.17%1.2M$5.5M−23,440 (−1.9%)June 30, 2026
10The Goldman Sachs Group Inc2.14%1.2M$5.4M+94,187 (+8.3%)June 30, 2026
11State Street Corp1.82%1.0M$4.6M+82,900 (+8.7%)June 30, 2026
12Propel Bio Management LLC1.72%983K$4.4M−346,829 (−26.1%)June 30, 2026
13NAN FUNG TRINITY (HK) Ltd1.67%957K$4.2M—June 30, 2026
14683 Capital Management LLC1.35%770K$3.4M—March 31, 2026
15Diametric Capital, LP1.32%755K$3.3M+143,501 (+23.5%)June 30, 2026
16J. Goldman & Co LP1.19%678K$3.0M+37,643 (+5.9%)June 30, 2026
17SILVERARC CAPITAL MANAGEMENT, LLC1.07%610K$2.7M−38,535 (−5.9%)June 30, 2026
18Rubric Capital Management LP1.06%609K$2.7M+608,771 (0.0%)June 30, 2026
19Stonepine Capital Management Llc0.97%557K$2.5M−189,303 (−25.4%)June 30, 2026
20Northern Trust Corp0.97%553K$2.4M+116,657 (+26.8%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 8.9M shares and 5 cut 711K.

ABEO top mutual fund and ETF holders

19 largest
Abeona Therapeutics Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.67%1.5M$6.8M—August 31, 2026
2iShares Russell 2000 ETF2.08%1.2M$5.3M−13,760 (−1.1%)September 30, 2026
3Fidelity Small Cap Index0.84%479K$2.1M+1,727 (+0.4%)July 31, 2026
4iShares Russell 2000 Value ETF0.77%438K$1.9M+664 (+0.2%)September 30, 2026
5Simplify Propel Opportunities ETF0.48%276K$1.2M—September 30, 2026
6Fidelity Extended Market Index0.48%272K$1.2M−1,462 (−0.5%)August 31, 2026
7Vanguard Russell 2000 ETF0.44%252K$1.1M+6,662 (+2.7%)August 31, 2026
8iShares Micro-Cap ETF0.25%145K$643,710−1,002 (−0.7%)September 30, 2026
9iShares Core S&P Total US Stock Mkt ETF0.21%120K$531,830+100 (+0.1%)September 30, 2026
10Northern Small Cap Value0.20%116K$511,776+115,525 (0.0%)June 30, 2026
11Stt Strt SPDR® Russell2000 US SmCapETF0.20%115K$509,902+5,504 (+5.0%)August 31, 2026
12Schwab Small Cap Index0.18%105K$465,513—August 31, 2026
13Fidelity Total Market Index0.17%99K$436,537—August 31, 2026
14Fidelity Nasdaq Composite Index0.17%96K$425,475+63,281 (+193.1%)August 31, 2026
15WisdomTree US SmallCap Earnings ETF0.16%94K$416,814—September 30, 2026
16Fidelity Series Total Market Index0.15%85K$374,782—August 31, 2026
17Goldman Sachs ActiveBeta® US SmCp Eq ETF0.13%76K$338,691—September 30, 2026
18iShares Russell 2000 Small-Cap Idx Instl0.13%76K$335,223—August 31, 2026
19Avantis US Small Cap Equity ETF0.12%69K$306,791+186 (+0.3%)September 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

ABEO insider transactions

latest 20
Abeona Therapeutics Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-02-02Eric CrombezSell$5.0916,284$82,886
2026-02-02Leila AllandSell$5.0918,065$91,951
2026-02-02Mark AlvinoSell$5.092,000$10,180
2026-02-02Christine Berni SilversteinSell$5.0920,070$102,156
2026-01-22Brendan M O'malleySell$5.3313,578$72,371
2026-01-22Joseph Walter VazzanoSell$5.3318,666$99,490
2026-01-22Madhav VasanthavadaSell$5.2912,610$66,707
2026-01-22Vishwas SeshadriSell$5.3369,832$372,205
2026-01-21Mark AlvinoSell$5.2313,500$70,605
2025-12-29Vishwas SeshadriSell$5.3125,000$132,750
2025-11-13Mark AlvinoSell$4.7415,000$71,100
2025-10-16Vishwas SeshadriSell$5.49249$1,367
2025-09-30Vishwas SeshadriSell$5.2425,000$131,000
2025-09-29Joseph Walter VazzanoSell$5.399,035$48,699
2025-09-29Vishwas SeshadriSell$5.3919,274$103,887
2025-09-29Brendan M O'malleySell$5.399,366$50,483
2025-09-22Brendan M O'malleySell$5.43688$3,736
2025-07-22Joseph Walter VazzanoSell$6.641,502$9,973
2025-07-09Brendan M O'malleySell$5.8617,428$102,128
2025-07-09Christine Berni SilversteinSell$5.8613,093$76,725

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

ABEO shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns ABEO

Institutional investors own 75.1% of Abeona Therapeutics's shares and insiders 10.96%. The largest holder is Nantahala Capital Management, LLC with 17.96% of the shares (10.3M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 5 reduced their stake in the latest filings. Short interest is 31.69% of the float, or 12.15 days of average trading volume. The share count rose 8,173.2% since 2014.

Related: ABEO analyst forecast, ABEO key metrics. See the ABEO stock overview for the latest quote and news.

ABEO ownership FAQ

Who owns the most Abeona Therapeutics stock?

The largest shareholders of Abeona Therapeutics are Nantahala Capital Management, LLC (17.96%), BlackRock Inc (5.86%), Cable Car Capital LLC (5.26%), AIGH Capital Management, LLC (5.22%), Vanguard Capital Management, LLC (3.87%).

What percentage of Abeona Therapeutics is owned by institutions?

Institutions hold 75.1% of Abeona Therapeutics's shares outstanding; insiders hold 10.96%.

Which funds own Abeona Therapeutics?

The largest fund holders of Abeona Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.67%), iShares Russell 2000 ETF (2.08%), Fidelity Small Cap Index (0.84%), iShares Russell 2000 Value ETF (0.77%), Simplify Propel Opportunities ETF (0.48%).

What is Abeona Therapeutics's short interest?

16.9M shares of Abeona Therapeutics were sold short, 31.69% of the float; at the average daily volume it would take 12.15 days to cover.

Are insiders buying or selling Abeona Therapeutics?

Of the latest 20 reported insider transactions in Abeona Therapeutics (since July 9, 2025), 0 were purchases and 20 were sales.

How many shares of Abeona Therapeutics are outstanding?

Abeona Therapeutics has 57.2M shares outstanding, of which 36.9M are in the public float.

Biotechnology: ownership